Related references
Note: Only part of the references are listed.Idebenone Decreases Aβ Pathology by Modulating RAGE/Caspase-3 Signaling and the Aβ Degradation Enzyme NEP in a Mouse Model of AD
Hyun-ju Lee et al.
BIOLOGY-BASEL (2021)
Plasma idebenone monitoring in Friedreich's ataxia patients during a long-term follow-up
Abraham J. Paredes-Fuentes et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Leber's hereditary optic neuropathy: course of disease in consideration of idebenone treatment and type of mutation
Felix Tonagel et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2021)
Novel Short-Chain Quinones to Treat Vision Loss in a Rat Model of Diabetic Retinopathy
Abraham Daniel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Idebenone: When an antioxidant is not an antioxidant
Nuri Gueven et al.
REDOX BIOLOGY (2021)
Cytoprotective Effects of Punicalagin on Hydrogen-Peroxide-Mediated Oxidative Stress and Mitochondrial Dysfunction in Retinal Pigment Epithelium Cells
Maria Elisabetta Clementi et al.
ANTIOXIDANTS (2021)
Effectiveness of idebenone nanorod formulations in the treatment of Alzheimer's disease
Yuying Huang et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Functions and Diseases of the Retinal Pigment Epithelium
Song Yang et al.
FRONTIERS IN PHARMACOLOGY (2021)
The Relationship between Mitochondria and Neurodegeration in the Eye: A Review
Hongtao Liu et al.
APPLIED SCIENCES-BASEL (2021)
Therapeutic Effect of Idebenone on Rats with Vascular Dementia via the MicroRNA-216a/RSK2/NF-κB Axis
Xudong Qian et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2021)
Nrf2-ARE signaling in cellular protection: Mechanism of action and the regulatory mechanisms
Pallab Shaw et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Long-term data with idebenone on respiratory function outcomes in patients with Duchenne muscular dystrophy
Laurent Servais et al.
NEUROMUSCULAR DISORDERS (2020)
Idebenone Has Distinct Effects on Mitochondrial Respiration in Cortical Astrocytes Compared to Cortical Neurons Due to Differential NQO1 Activity
Sausan M. Jaber et al.
JOURNAL OF NEUROSCIENCE (2020)
Punicalagin Protects Human Retinal Pigment Epithelium Cells from Ultraviolet Radiation-Induced Oxidative Damage by Activating Nrf2/HO-1 Signaling Pathway and Reducing Apoptosis
Maria Elisabetta Clementi et al.
ANTIOXIDANTS (2020)
Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy
Claudia B. Catarino et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2020)
Not All Stressors Are Equal: Mechanism of Stressors on RPE Cell Degeneration
Yao Tong et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
DHA protects PC12 cells against oxidative stress and apoptotic signals through the activation of the NFE2L2/HO-1 axis
Maria Elisabetta Clementi et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)
Targeting NRF2 for the Treatment of Friedreich's Ataxia: A Comparison among Drugs
Sara Petrillo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Punicalagin reduces H2O2-induced cytotoxicity and apoptosis in PC12 cells by modulating the levels of reactive oxygen species
Maria Elisabetta Clementi et al.
NUTRITIONAL NEUROSCIENCE (2018)
THE KEAP1-NRF2 SYSTEM: A THIOL-BASED SENSOR-EFFECTOR APPARATUS FOR MAINTAINING REDOX HOMEOSTASIS
Masayuki Yamamoto et al.
PHYSIOLOGICAL REVIEWS (2018)
Oxidative Stress in Age-Related Macular Degeneration: Nrf2 as Therapeutic Target
Ilaria Bellezza
FRONTIERS IN PHARMACOLOGY (2018)
MOMP, cell suicide as a BCL-2 family business
Halime Kalkavan et al.
CELL DEATH AND DIFFERENTIATION (2018)
Targeting mitochondrial function to treat optic neuropathy
Nuri Gueven et al.
MITOCHONDRION (2017)
Idebenone in Friedreich ataxia and Leber's hereditary optic neuropathy: close mechanisms, similar therapy?
Manuel Schiff et al.
BRAIN (2016)
Idebenone: A Review in Leber's Hereditary Optic Neuropathy
Katherine A. Lyseng-Williamson
DRUGS (2016)
Pharmacology of the retinal pigment epithelium, the interface between retina and body system
Olaf Strauss
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial
Gunnar M. Buyse et al.
LANCET (2015)
Idebenone Prevents Oxidative Stress, Cell Death and Senescence of Retinal Pigment Epithelium Cells by Stabilizing BAX/Bcl-2 Ratio
Nicole Arend et al.
OPHTHALMOLOGICA (2015)
Border between natural product and drug: Comparison of the related benzoquinones idebenone and coenzyme Q(10)
Nuni Gueyen et al.
REDOX BIOLOGY (2015)
Co-enzyme Q10 and idebenone use in Friedreich's ataxia
Michael H. Parkinson et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis
Suryakant K. Niture et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Mitochondrial Dysfunction in Retinal Diseases
Megha Barot et al.
CURRENT EYE RESEARCH (2011)
Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: Results from a 12 month, double-blind, randomized placebo-controlled trial
Gunnar M. Buyse et al.
NEUROMUSCULAR DISORDERS (2011)
NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy Levels
Roman H. Haefeli et al.
PLOS ONE (2011)
Control of mitochondrial apoptosis by the Bcl-2 family
Joslyn K. Brunelle et al.
JOURNAL OF CELL SCIENCE (2009)
The contribution of DNA repair and antioxidants in determining cell type-specific resistance to oxidative stress
Stuart G. Jarrett et al.
FREE RADICAL RESEARCH (2006)
Role of mitochondrial DNA in toxic responses to oxidative stress
B Van Houten et al.
DNA REPAIR (2006)
The retinal pigment epithelium in visual function
O Strauss
PHYSIOLOGICAL REVIEWS (2005)
Nrf2, a multi-organ protector?
JM Lee et al.
FASEB JOURNAL (2005)
Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation
M Kobayashi et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Quinone analogues regulate mitochondrial substrate competitive oxidation
JJ Brière et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study
H Gutzmann et al.
PHARMACOPSYCHIATRY (2002)